AlzeCure Pharma AB was founded in 2016, which characterizes our business and work environment, which is open, creative and dynamic. Innovation ability and flexibility are therefore qualities that we value highly.
The company’s activities are focused on the development of new drugs for the treatment of neurodegenerative diseases, such as e.g. Alzheimer’s disease and Parkinson’s disease, as well as pain. The research is conducted at Huddinge Hospital (Novum).
We are now announcing a permanent employment in in vivo pharmacology with a focus on drug development. The service is lab-oriented, and we therefore value such previous experience highly.
- You should be a biomedical analyst or have a master’s or doctoral degree. We value work experience highly and you should have more than 5 years of previous experience in industrial drug development.
- You should have very good experience and knowledge in in vivo pharmacology, handling of small animals, substance administration (p.o., s.c., i.v.) and sampling. Experience of behavioral tests and surgery is considered a merit as well as basic knowledge in sectioning and histology.
- Previous experience of biochemical biomarker analysis in tissue (CSF, plasma, brain) is a merit.
- Good knowledge in neurology and understanding of the basic mechanisms behind the diseases is desirable.
The employment is a permanent employment with immediate access. The workplace is located at Huddinge Hospital, Huddinge. In order to achieve a more even gender distribution, we are happy to see female applicants.
If this seems interesting, then you are welcome to send an application with a short description of your background, CV and two reference persons by March 24 to email@example.com.
If you have specific questions, please contact Johan Sandin, 070-3738824.